Diagnostics pioneers Abacus Diagnostica, Kaivogen and Labrox are now together Uniogen

Three Finnish life science experts – Abacus Diagnostica, a frontrunner in molecular testing and rapid PCR test systems, Kaivogen, a specialist in immunoassays and antibody tests, and Labrox, an innovator of high technology laboratory instruments and diagnostic readers – announced in September 2021 that they are joining forces to form a global diagnostics pioneer. The share swap agreement between the companies has […]

Getting to know our future colleagues and what’s coming up next

As we earlier announced, we are combining three companies (Labrox, Kaivogen and Abacus Diagnostica). Our goal is to grow together and change the future of diagnostics for the better! Together the three of us can grow and serve others better than individually – each of these companies has knowledge and resources for something that others don’t. So this is a […]

Minimize interference in your LF immunoassays exploiting UCNPs

Upconverting nanoparticles (UCNPs) as a measurement technology enables more sensitive results to your diagnostic assays. Our upcoming biotech company offers these UCNP – particles and readers as a part of its product portfolio. The new company, including three frontrunners in the field, will provide a total solution for point-of-care testing. Anywhere and at any time! Stay tuned for updates. Labrox already provides a UPCON […]

Abacus Diagnostica, Kaivogen and Labrox joining forces to form a global diagnostics pioneer

Abacus Diagnostica, Kaivogen and Labrox joining forces to form a global diagnostics pioneer – Enabling the right diagnosis and care at the patient’s first appointment Three Finnish biotech companies – Abacus Diagnostica, Kaivogen and Labrox – are joining forces to form an international frontrunner in vitro diagnostics. The new company will provide the global market with a unique total solution […]